Z-FA-FMK

1 1

Selleck Chemicals

S7391-1MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

Z-FA-FMK is an inhibitor of Cysteine Proteases used in studies of protease biology. It is especially relevant in inflammation models, where defined compound exposure can be linked to proteolytic processing and cleavage-dependent signaling. Dose-response comparison, orthogonal validation, and secondary assay follow-up can further sharpen mechanistic interpretation.

By inhibiting Cysteine Proteases, Z-FA-FMK can be used to examine proteolytic processing and cleavage-dependent signaling. This target class is commonly examined through protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping. In inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving Cysteine Proteases
  • Concentration-response inhibition and target-dependence studies
  • Protease-activity, cleavage, and substrate-processing assays
  • Phenotypic profiling in inflammation models

Overall, Z-FA-FMK is appropriate when a defined chemical perturbant is needed to connect Cysteine Proteases with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
Cysteine Proteases
Target Class:
Protease
Research Area:
Inflammation
CAS No.:
197855-65-5
Molecular Weight:
386.42
Formula:
C₂₁H₂₃FN₂O₄
SMILES:
CC(C(=O)CF)NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.